메뉴 건너뛰기




Volumn 7, Issue , 2007, Pages

Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL RESEARCH; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOENCEPHALOGRAPHY; FOLLOW UP; GOLD STANDARD; LONGITUDINAL STUDY; MEDICAL SPECIALIST; OBSERVATIONAL STUDY; PARKINSONISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; TRANSCRANIAL DUPLEX SCANNING; CLINICAL PROTOCOL; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; ECHOGRAPHY; HUMAN; METHODOLOGY; PROSPECTIVE STUDY;

EID: 35448975236     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-7-28     Document Type: Article
Times cited : (10)

References (48)
  • 2
    • 0026514953 scopus 로고
    • Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
    • 1564476
    • Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184. 1564476
    • (1992) J Neurol Neurosurg Psychiatry , vol.55 , pp. 181-184
    • Hughes, A.J.1    Daniel, S.E.2    Kilford, L.3    Lees, A.J.4
  • 3
    • 0030806395 scopus 로고    scopus 로고
    • Issues in the early diagnosis of Parkinson's disease
    • 9222271
    • Koller WC, Montgomery EB: Issues in the early diagnosis of Parkinson's disease. Neurology 1997, 49:S10-25. 9222271
    • (1997) Neurology , vol.49
    • Koller, W.C.1    Montgomery, E.B.2
  • 5
    • 0025939232 scopus 로고
    • Accuracy of clinical diagnosis in parkinsonism-a prospective study
    • 1913360
    • Rajput AH, Rozdilsky B, Rajput A: Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci 1991, 18:275-278. 1913360
    • (1991) Can J Neurol Sci , vol.18 , pp. 275-278
    • Rajput, A.H.1    Rozdilsky, B.2    Rajput, A.3
  • 7
    • 3142532430 scopus 로고    scopus 로고
    • Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease
    • 10.1016/S1474-4422(04)00823-3 15261607
    • Clarke CE: Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease. Lancet Neurol 2004, 3:466-474. 10.1016/ S1474-4422(04)00823-3 15261607
    • (2004) Lancet Neurol , vol.3 , pp. 466-474
    • Clarke, C.E.1
  • 8
    • 1942488906 scopus 로고    scopus 로고
    • Functional brain imaging in the differential diagnosis of Parkinson's disease
    • 10.1016/S1474-4422(04)00736-7 15099543
    • Piccini P, Whone A: Functional brain imaging in the differential diagnosis of Parkinson's disease. Lancet Neurol 2004, 3:284-290. 10.1016/ S1474-4422(04)00736-7 15099543
    • (2004) Lancet Neurol , vol.3 , pp. 284-290
    • Piccini, P.1    Whone, A.2
  • 9
    • 12744259998 scopus 로고    scopus 로고
    • Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients
    • 10.1007/s00415-004-0549-2 15592735
    • Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, Steinling M, Destee A: Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients. J Neurol 2004, 251:1383-1392. 10.1007/s00415-004-0549-2 15592735
    • (2004) J Neurol , vol.251 , pp. 1383-1392
    • Dujardin, K.1    Defebvre, L.2    Duhamel, A.3    Lecouffe, P.4    Rogelet, P.5    Steinling, M.6    Destee, A.7
  • 11
    • 5644230952 scopus 로고    scopus 로고
    • New developments in diagnosis and treatment of Parkinson's disease - From basic science to clinical applications
    • Storch A, Hofer A, Kruger R, Schulz JB, Winkler J, Gerlach M: New developments in diagnosis and treatment of Parkinson's disease - from basic science to clinical applications. J Neurol 2004, 251 Suppl 6:VI/ 33-8
    • (2004) J Neurol , vol.251 , Issue.SUPPL. 6
    • Storch, A.1    Hofer, A.2    Kruger, R.3    Schulz, J.B.4    Winkler, J.5    Gerlach, M.6
  • 12
    • 0028200997 scopus 로고
    • Echogenicity of the brainstem raphe in patients with major depression
    • 10.1016/0925-4927(94)90002-7 10711796
    • Becker G, Struck M, Bogdahn U, Becker T: Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 1994, 55:75-84. 10.1016/0925-4927(94)90002-7 10711796
    • (1994) Psychiatry Res , vol.55 , pp. 75-84
    • Becker, G.1    Struck, M.2    Bogdahn, U.3    Becker, T.4
  • 13
    • 0035215373 scopus 로고    scopus 로고
    • Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease?
    • 11687754
    • Fernandez HH, Friedman JH, Fischman AJ, Noto RB, Lannon MC: Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease? Med Sci Monit 2001, 7:1339-1343. 11687754
    • (2001) Med Sci Monit , vol.7 , pp. 1339-1343
    • Fernandez, H.H.1    Friedman, J.H.2    Fischman, A.J.3    Noto, R.B.4    Lannon, M.C.5
  • 14
    • 0042388390 scopus 로고    scopus 로고
    • Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients
    • 12843212
    • Huang WS, Chiang YH, Lin JC, Chou YH, Cheng CY, Liu RS: Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients. J Nucl Med 2003, 44:999-1005. 12843212
    • (2003) J Nucl Med , vol.44 , pp. 999-1005
    • Huang, W.S.1    Chiang, Y.H.2    Lin, J.C.3    Chou, Y.H.4    Cheng, C.Y.5    Liu, R.S.6
  • 16
    • 0028172225 scopus 로고
    • Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism
    • 10.1097/00006231-199410000-00006 7838444
    • Schwarz J, Antonini A, Tatsch K, Kirsch CM, Oertel WH, Leenders KL: Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism. Nucl Med Commun 1994, 15:806-813. 10.1097/ 00006231-199410000-00006 7838444
    • (1994) Nucl Med Commun , vol.15 , pp. 806-813
    • Schwarz, J.1    Antonini, A.2    Tatsch, K.3    Kirsch, C.M.4    Oertel, W.H.5    Leenders, K.L.6
  • 17
    • 0242319844 scopus 로고    scopus 로고
    • How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?
    • 10.1002/mds.10581 14531048
    • Morrish PK: How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease? Mov Disord 2003, 18 Suppl 7:S63-70. 10.1002/mds.10581 14531048
    • (2003) Mov Disord , vol.18 , Issue.SUPPL. 7
    • Morrish, P.K.1
  • 18
    • 14044250925 scopus 로고    scopus 로고
    • The meaning of negative DAT SPECT and F-Dopa PET scans in patients with clinical Parkinson's disease
    • author reply 117-8. 10.1002/mds.20304
    • Morrish P: The meaning of negative DAT SPECT and F-Dopa PET scans in patients with clinical Parkinson's disease. Mov Disord 2005, 20:117; author reply 117-8. 10.1002/mds.20304
    • (2005) Mov Disord , vol.20 , pp. 117
    • Morrish, P.1
  • 21
    • 0032765888 scopus 로고    scopus 로고
    • Iron accumulation in the substantia nigra in rats visualized by ultrasound
    • 10.1016/S0301-5629(99)00046-0 10461717
    • Berg D, Grote C, Rausch WD, Maurer M, Wesemann W, Riederer P, Becker G: Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 1999, 25:901-904. 10.1016/ S0301-5629(99)00046-0 10461717
    • (1999) Ultrasound Med Biol , vol.25 , pp. 901-904
    • Berg, D.1    Grote, C.2    Rausch, W.D.3    Maurer, M.4    Wesemann, W.5    Riederer, P.6    Becker, G.7
  • 23
    • 0028869760 scopus 로고
    • Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography
    • 7824114
    • Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K: Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995, 45:182-184. 7824114
    • (1995) Neurology , vol.45 , pp. 182-184
    • Becker, G.1    Seufert, J.2    Bogdahn, U.3    Reichmann, H.4    Reiners, K.5
  • 24
    • 0037435514 scopus 로고    scopus 로고
    • Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes
    • 10.1159/000071230 12525721
    • Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D: Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003, 60:74-77. 10.1159/000071230 12525721
    • (2003) Neurology , vol.60 , pp. 74-77
    • Walter, U.1    Niehaus, L.2    Probst, T.3    Benecke, R.4    Meyer, B.U.5    Dressler, D.6
  • 25
    • 0034935922 scopus 로고    scopus 로고
    • Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
    • 10.1007/s004150170114 11569897
    • Berg D, Siefker C, Becker G: Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001, 248:684-689. 10.1007/s004150170114 11569897
    • (2001) J Neurol , vol.248 , pp. 684-689
    • Berg, D.1    Siefker, C.2    Becker, G.3
  • 26
    • 35448995511 scopus 로고    scopus 로고
    • Hyposmia, midbrain hyperechogenity and Parkinson's disease: Findings in a population-based study
    • 10.1002/mds.21161
    • Seppi K, Stockner S, Kiechl S, Schwaiger M, Sawires M, Willeit J, Poewe W: Hyposmia, midbrain hyperechogenity and Parkinson's Fisease: findings in a population-based study. Movement Disorders 2007, 22:S10 10.1002/ mds.21161
    • (2007) Movement Disorders , vol.22
    • Seppi, K.1    Stockner, S.2    Kiechl, S.3    Schwaiger, M.4    Sawires, M.5    Willeit, J.6    Poewe, W.7
  • 29
    • 33244497832 scopus 로고    scopus 로고
    • Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease
    • 10.1002/mds.20669 16114024
    • Schweitzer KJ, Hilker R, Walter U, Burghaus L, Berg D: Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease. Mov Disord 2006, 21:94-98. 10.1002/mds.20669 16114024
    • (2006) Mov Disord , pp. 94-98
    • Schweitzer, K.J.1    Hilker, R.2    Walter, U.3    Burghaus, L.4    Berg, D.5
  • 30
    • 33644766113 scopus 로고    scopus 로고
    • Can ultrasonography of the substantia nigra replace FP-CIT-SPECT?(abstract)
    • 15878582
    • Tromp SC, Vlaar AMM, Weber WEJ, Mess WH: Can ultrasonography of the substantia nigra replace FP-CIT-SPECT?(abstract). Parkinsonism Relat Disord 2005, 11:221. 15878582
    • (2005) Parkinsonism Relat Disord , vol.11 , pp. 221
    • Tromp, S.C.1    Vlaar, A.M.M.2    Weber, W.E.J.3    Mess, W.H.4
  • 32
    • 0000224448 scopus 로고
    • The Unified Parkinson's Disease Rating Scale
    • Florham Park, NJ, Marcmillan Health Care Information. Fahn S, Marsden CD, Calne DB and Goldstein M
    • Fahn S, Elton RL: The Unified Parkinson's Disease Rating Scale Recent developments in Parkinson's disease Florham Park, NJ, Marcmillan Health Care Information. Fahn S, Marsden CD, Calne DB and Goldstein M 1987:153-164.
    • (1987) Recent Developments in Parkinson's Disease , pp. 153-164
    • Fahn, S.1    Elton, R.L.2
  • 33
    • 6844244961 scopus 로고    scopus 로고
    • Course and treatment (handbook) Academic press San Diago, California
    • Caplan B: Neurological disorders. Course and treatment (handbook) Academic press San Diago, California 1996
    • (1996) Neurological Disorders
    • Caplan, B.1
  • 34
    • 72949151592 scopus 로고
    • A rating scale for depression
    • 14399272
    • Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 14399272
    • (1960) J Neurol Neurosurg Psychiatry , vol.23 , pp. 56-62
    • Hamilton, M.1
  • 36
    • 0030933980 scopus 로고    scopus 로고
    • 'Sniffin' sticks': Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold
    • 10.1093/chemse/22.1.39 9056084
    • Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G: 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997, 22:39-52. 10.1093/chemse/22.1.39 9056084
    • (1997) Chem Senses , vol.22 , pp. 39-52
    • Hummel, T.1    Sekinger, B.2    Wolf, S.R.3    Pauli, E.4    Kobal, G.5
  • 39
    • 0027337422 scopus 로고
    • Parkinson's Disease Society Brain Bank, London: Overview and research
    • 8360656
    • Daniel SE, Lees AJ: Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993, 39:165-172. 8360656
    • (1993) J Neural Transm Suppl , vol.39 , pp. 165-172
    • Daniel, S.E.1    Lees, A.J.2
  • 41
    • 4043166568 scopus 로고    scopus 로고
    • Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis
    • 10.1002/mds.20083 15197700
    • Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ: Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004, 19:630-640. 10.1002/ mds.20083 15197700
    • (2004) Mov Disord , vol.19 , pp. 630-640
    • Zijlmans, J.C.1    Daniel, S.E.2    Hughes, A.J.3    Revesz, T.4    Lees, A.J.5
  • 45
    • 35449005590 scopus 로고    scopus 로고
    • Transcranial sonography (TCS) of the substantia nigra (SN)-biological and clinical significance in patients with parkinsonian syndromes (PS)
    • Weise D, Lorenz R, Schliesser M, Reiners K, Classen J: Transcranial sonography (TCS) of the substantia nigra (SN)-biological and clinical significance in patients with parkinsonian syndromes (PS). Movement Disorders 2007, 22:S194
    • (2007) Movement Disorders , vol.22
    • Weise, D.1    Lorenz, R.2    Schliesser, M.3    Reiners, K.4    Classen, J.5
  • 47
    • 0035884536 scopus 로고    scopus 로고
    • Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy
    • 10.1016/S0006-3223(01)01190-8 11566164
    • Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G: Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 2001, 50:463-467. 10.1016/S0006-3223(01)01190-8 11566164
    • (2001) Biol Psychiatry , vol.50 , pp. 463-467
    • Berg, D.1    Jabs, B.2    Merschdorf, U.3    Beckmann, H.4    Becker, G.5
  • 48
    • 33750569168 scopus 로고    scopus 로고
    • Drug-induced parkinsonism
    • 10.1517/14740338.5.6.759 17044803
    • Mena MA, de Yebenes JG: Drug-induced parkinsonism. Expert Opin Drug Saf 2006, 5:759-771. 10.1517/14740338.5.6.759 17044803
    • (2006) Expert Opin Drug Saf , vol.5 , pp. 759-771
    • Mena, M.A.1    de Yebenes, J.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.